Scarica l'app Stockscreener
85.58
0.31%
-0.27
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MET Giù?
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$85.85
Aprire:
$87.1
Volume 24 ore:
7.88M
Relative Volume:
2.20
Capitalizzazione di mercato:
$55.07B
Reddito:
$77.59B
Utile/perdita netta:
$3.62B
Rapporto P/E:
16.55
EPS:
5.1701
Flusso di cassa netto:
$16.53B
1 W Prestazione:
-2.28%
1M Prestazione:
+5.12%
6M Prestazione:
+4.74%
1 anno Prestazione:
+8.95%
Intervallo 1D:
$85.38
$87.69
Intervallo di 1 settimana:
$85.38
$89.62
Portata 52W:
$67.33
$89.62
Metlife Inc Stock (MET) Company Profile
Nome
Metlife Inc
Settore
Industria
Telefono
212-578-5500
Indirizzo
200 PARK AVENUE, NEW YORK, NY
Compare MET vs MFC, AFL, PRU, PUK
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MET
Metlife Inc
|
85.58 | 55.07B | 77.59B | 3.62B | 16.53B | 5.1701 |
MFC
Manulife Financial Corp
|
40.61 | 67.64B | 44.31B | 4.69B | 20.94B | 2.5185 |
AFL
Aflac Inc
|
115.47 | 58.77B | 18.11B | 4.64B | 2.93B | 8.812 |
PRU
Prudential Financial Inc
|
106.53 | 37.00B | 62.83B | 3.60B | 9.79B | 9.7297 |
PUK
Prudential Plc Adr
|
26.79 | 33.47B | 27.81B | 4.12B | 1.87B | 3.07 |
Metlife Inc Stock (MET) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-06 | Downgrade | Evercore ISI | Outperform → In-line |
| 2025-12-16 | Iniziato | Mizuho | Outperform |
| 2025-09-19 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2025-09-16 | Iniziato | Wolfe Research | Outperform |
| 2025-01-23 | Iniziato | BMO Capital Markets | Market Perform |
| 2024-10-09 | Iniziato | TD Cowen | Buy |
| 2024-09-05 | Iniziato | Barclays | Overweight |
| 2024-01-08 | Aggiornamento | Goldman | Neutral → Buy |
| 2023-11-17 | Ripresa | Barclays | Overweight |
| 2023-10-05 | Iniziato | Deutsche Bank | Hold |
| 2023-09-14 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-01-09 | Downgrade | Goldman | Buy → Neutral |
| 2022-12-09 | Downgrade | Jefferies | Buy → Hold |
| 2022-09-22 | Iniziato | Raymond James | Mkt Perform |
| 2022-06-23 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2022-05-24 | Iniziato | Citigroup | Buy |
| 2022-01-26 | Iniziato | Jefferies | Buy |
| 2022-01-21 | Iniziato | Wolfe Research | Peer Perform |
| 2022-01-12 | Reiterato | UBS | Buy |
| 2022-01-05 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2021-12-03 | Iniziato | Goldman | Buy |
| 2021-04-21 | Iniziato | UBS | Buy |
| 2021-01-06 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2020-12-08 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-12-04 | Iniziato | Goldman | Neutral |
| 2020-11-17 | Iniziato | Barclays | Overweight |
| 2020-06-01 | Ripresa | BofA/Merrill | Buy |
| 2020-03-16 | Aggiornamento | Citigroup | Sell → Neutral |
| 2020-01-07 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2019-07-16 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-03-19 | Downgrade | Sandler O'Neill | Buy → Hold |
| 2019-01-16 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-01-02 | Aggiornamento | Sandler O'Neill | Hold → Buy |
| 2018-06-04 | Downgrade | Goldman | Buy → Neutral |
| 2018-04-25 | Iniziato | Credit Suisse | Outperform |
| 2018-03-26 | Aggiornamento | Atlantic Equities | Neutral → Overweight |
| 2018-01-02 | Iniziato | Deutsche Bank | Hold |
| 2017-11-10 | Downgrade | Sandler O'Neill | Buy → Hold |
| 2017-11-03 | Reiterato | RBC Capital Mkts | Outperform |
| 2017-05-25 | Aggiornamento | FBR & Co. | Mkt Perform → Outperform |
| 2017-03-06 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2017-01-26 | Iniziato | Citigroup | Sell |
| 2016-12-09 | Downgrade | Standpoint Research | Buy → Hold |
Mostra tutto
Metlife Inc Borsa (MET) Ultime notizie
MetLife Korea Creates 100-Pyeong 'School Forest' at Seoul's Ssangmun Elementary - Seoul Economic Daily
MetLife Inc (MET) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
MetLife Inc (MET) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
MetLife Inc (MET) Institutional Confidence - TradingKey
MetLife Inc (MET) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
MetLife Inc. stock outperforms competitors despite losses on the day - MarketWatch
Ex-Sidley Austin Partner Sues MetLife Over Disability Benefits - Bloomberg Law News
MetLife Inc (MET) Valuation: PE, PB & Fair Value Analysis - TradingKey
MetLife Inc (MET) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
MetLife (MET) Stock And The Valuation Puzzle After Strong Multi‑Year Gains - Yahoo Finance
Recurring premiums, MetLife Pet Insurance targets budget-conscious owners - AD HOC NEWS
MetLife Inc. Stock (US59156R1086): Near Record High As Valuation Premium Widens - AD HOC NEWS
MetLife Expands Settlement Offerings With New Flex Agreement And Valuation Upside - Yahoo Finance
ZAWYA: Orange Jordan & MetLife partner to offer insurance services via Orange Money - TradingView
MetLife Appoints Najla Frayha as Chief Marketing Officer, U.S. Group Benefits - hrtoday.in
Is MetLife stock outperforming the S&P 500? - MSN
MetLife’s New Flexible Settlement Tool Could Reshape Its Structured Solutions Story - Sahm
MetLife Inc. stock outperforms competitors on strong trading day - MarketWatch
MetLife Stadium? Lumen Field? Not during the World Cup - Fast Company
MetLife on Track for Record High Close -- Data Talk - Moomoo
Metlife Preferreds Update: Series A Drops From Hold To Sell; Others Stay Holds (MET.PR.A) - Seeking Alpha
MetLife broadens settlement solutions portfolio with NQA-FA - MSN
MetLife Inc. stock rises Thursday, still underperforms market - MarketWatch
MetLife (MET) director McKenzie credited 169 shares via deferred dividend reinvestment - Stock Titan
[Form 4] METLIFE INC Insider Trading Activity - Stock Titan
MetLife (NYSE: MET) director adds 39 deferred shares via dividends - Stock Titan
MetLife (MET) director Jeh C. Johnson acquires 61 shares through deferred dividend reinvestment - Stock Titan
MetLife (MET) director granted 42 shares via dividend reinvestment - Stock Titan
MetLife (MET) director adds 20 shares via deferred dividend reinvestment - Stock Titan
MetLife (NYSE: MET) director gains 7 shares via deferred compensation plan - Stock Titan
MetLife (NYSE: MET) director gains 678 shares via deferred stock plan - Stock Titan
MetLife (MET) U.S. Business president awarded 127 shares via deferred plan - Stock Titan
AI's Inflationary Impact on Economy, Says MetLife's Drew Matus - GuruFocus
MetLife Broadens Settlement Solutions Portfolio With NQA-FA - Yahoo Finance
MetLife (MET) Unveils Flexible Settlement Agreement for Non-Phys - GuruFocus
MetLife launches deferred payment product for injury settlements - Investing.com
The ’Duck Stock’ Keeps Quietly Making Money for Shareholders - Investing.com
MetLife launches deferred payment product for injury settlements By Investing.com - Investing.com Canada
MetLife Launches New Deferred Payment Option for Non-Physical Injury Claims - marketscreener.com
MetLife Inc at Morgan Stanley US Financials Conference Transcript - GuruFocus
Lincoln National vs. MetLife: Which Financial Stock Is a Better Buy in 2026? - The Globe and Mail
MetLife Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
MetLife Inc. stock (US59156R1086): shares hover near 52-week high after solid Q1 earnings - AD HOC NEWS
$23M Settlement Ends MetLife’s Mortality Table Case - planadviser
Q1 Earnings Roundup: MetLife (NYSE:MET) And The Rest Of The Life Insurance Segment - Yahoo Finance
Metlife stock hits 52-week high at 85.31 USD - Investing.com
Metlife stock hits 52-week high at 85.31 USD By Investing.com - Investing.com Canada
METLIFE INC (NYSE:MET) Shows Strong Breakout Setup with High Technical and Quality Scores - ChartMill
Argus Adjusts Price Target on MetLife to $93 From $90, Maintains Buy Rating - marketscreener.com
MetLife Settles Mortality Table ERISA Lawsuit for $23M - plansponsor
MKL Stock Declines 15.4% in YTD: What Should Investors Do Now? - TradingView
Metlife Inc Azioni (MET) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.66%
0.54%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):